Apogee Therapeutics, Inc.
APGE
Revenue
0.00
0.000.00%
-Assets
800.66M
▼-23.00M▼-2.79%
3 Months ChangeLiabilities
27.02M
▲4.84M▲21.81%
3 Months ChangeFree Cash Flow
-31.99M
▼-31.99M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001104659-24-111027
2024-08-19
Form 8-K
ID: 0001104659-24-090690
2024-08-12
Form 10-Q
ID: 0000950170-24-095053
2024-08-12
Form 8-K
ID: 0001104659-24-088029
2024-06-07
Form 8-K
ID: 0001104659-24-069619
2024-05-28
Form 8-K
ID: 0001104659-24-065322
2024-05-15
Form 8-K
ID: 0001104659-24-061998
2024-05-13
Form 10-Q
ID: 0001558370-24-007861
2024-05-13
Form 8-K
ID: 0001104659-24-060195
2024-03-25
Form 8-K
ID: 0001104659-24-038161